To test this, dissociated tumor cells were injected into nude mice, and tumor-bearing mice were treated with functional perturbing anti-SDF1 antibody or with control anti-HSV Glycoprotein D (GD) antibody three times per week. This evidence concerns the gene CXCL12 and neoplasm.